Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | C10orf95-AS1 | Human | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of C10ORF95-AS1 mRNA | CTD | PMID:30851411 | C10orf95-AS1 | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of C10ORF95-AS1 mRNA | CTD | PMID:32763439 | C10orf95-AS1 | Human | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of C10ORF95-AS1 mRNA | CTD | PMID:27153756 | C10orf95-AS1 | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of C10ORF95-AS1 mRNA | CTD | PMID:27392435 | C10orf95-AS1 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of C10ORF95-AS1 mRNA | CTD | PMID:27392435 | C10orf95-AS1 | Human | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of C10ORF95-AS1 mRNA | CTD | PMID:30851411 | C10orf95-AS1 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of C10ORF95-AS1 mRNA | CTD | PMID:25351596 | C10orf95-AS1 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of C10ORF95-AS1 mRNA | CTD | PMID:25979313 | |